VituVingiSana wrote:enyands wrote:MaichBlack wrote:Kenya Seed have neither the technology nor the patent to the technology to do that. Unless they are acting as distributors for another company.
What I know is that with their seeds, they ADVICE farmers not to replant (apparently for better yield) but if you replant it actually grows!!!
Just read the story in the article above. It's like a science fiction movie. Monsanto and crew can even "switch" off ripening genes and other things which can only be "switched on" by using their fertilizers and other chemicals in very specific proportions. Soma link my friend!
They are creeping into the basic rights of human beings -food to make money .I don't call that brilliance I call it greed beyond the level a hyena can reach .
The same time they wanted to patent human genome where if you wanted to know if you have genes responsible for cancer then you pay this "gene company " a good amount of money then they can tell you you have genes that are carcinogenic so stop eating ....eat .... exercise ... a day and all that.
Thank God uncle Robert and his Sotomayor team shut it down and said a human genome structure can't be patented . I was listening to the closing statements and it was applausable
link What stopped you from sequencing the genome?
Common sense that the US judges had when passing the verdict is what stopped me .I can mail you the closing statements. If someone has common sense they will understand you can't patent what's God given right. Vvs do believe cloning human beings for the sake of generating profits to be morally, legally and logical right ???
SUPREME COURT OF THE UNITED STATES
No. 12–398
ASSOCIATION FOR MOLECULAR PATHOLOGY,
ET AL., PETITIONERS v. MYRIAD
GENETICS, INC., ET AL.
ON WRIT OF CERTIORARI TO THE UNITED STATES COURT OF
APPEALS FOR THE FEDERAL CIRCUIT [June 13, 2013]
JUSTICE THOMAS delivered the opinion of the Court.
Respondent Myriad Genetics, Inc. (Myriad), discovered
the precise location and sequence of two human genes,
mutations of which can substantially increase the risks of
breast and ovarian cancer. Myriad obtained a number
of patents based upon its discovery. This case involves
claims from three of them and requires us to resolve
whether a naturally occurring segment of deoxyribonucleic
acid (DNA) is patent eligible under 35 U. S. C. §101 by
virtue of its isolation from the rest of the human genome.
We also address the patent eligibility of synthetically
created DNA known as complementary DNA (cDNA), which
contains the same protein-coding information found in
a segment of natural DNA but omits portions within the
DNA segment that do not code for proteins. For the rea-
sons that follow,
we hold that a naturally occurring DNA
segment is a product of nature and not patent eligiblemerely because it has been isolated, but that cDNA is
patent eligible because it is not naturally occurring. We,
therefore, affirm in part and reverse in part the decision of
I can clarify more to you if you need dna classes and if I need help in buying kapchorwa, bamburi ,kk and IM bank I would be glad to be schooled by you.